ESC Premium Access

Extending the evidence: what did the FOURIER trial learns us on managing high risk patients?

Topic: Prevention
Organised by PACE-CME, supported with an educational grant provided by Amgen, Draupnir Bio ApS, Sanofi-Regeneron & The Medicines Company

Congress Session

About the speaker

Professor Marc Sabatine

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
16 presentations
1 follower

4 more presentations in this session

Introduction

Speaker: Professor J. Chapman (Paris, FR)

Thumbnail

Insights and lessons from the ODYSSEY outcomes trial: which patients benefit most?

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Targeting PCSK9: expanding knowledge and targeting new frontiers

Speaker: Professor J. Kastelein (Amsterdam, NL)

Thumbnail

Discussion

Speaker: Professor J. Chapman (Paris, FR) Professor J. Kastelein (Amsterdam, NL)

Thumbnail

Access the full session

PCSK9i, changing practice in cardiology: the emerging story

Speakers: Professor M. Sabatine, Professor J. Chapman, Professor P. Steg, Professor J. Kastelein, Professor J. Chapman...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk